Mr. Wonderful X Turn Therapeutics

​Join us for a conversation between Turn Therapeutics Founder and CEO Bradley Burnam and Kevin O’Leary (aka Mr. Wonderful) as they discuss Turn Therapeutics’ groundbreaking innovations in advanced wound care, infection control, and antimicrobial solutions.

​As healthcare systems worldwide seek more effective, non-toxic solutions to combat infection and improve patient outcomes, Turn Therapeutics is leading the way with patented technologies that redefine modern medical care. Hear from Bradley Burnam about the company's pioneering work, the vision driving its growth, and why investors are paying close attention to this disruptive force in the healthcare industry.

​This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please read the offering circular and risks for more information.

​Kevin O’Leary is a paid spokesperson for StartEngine. See his 17(b) disclosure here.